Financial statements Rbw Pharm
Balance sheet data of RBW PHARM
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 3 086,96 | 50,26 | 33,87 | 56,18 | 86,62 |
| A. Fixed assets | 3 004,96 | 0,00 | 0,85 | 0,00 | 34,20 |
| B. Current assets | 82,00 | 50,26 | 33,02 | 56,18 | 52,42 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 3 086,96 | 50,26 | 33,87 | 56,18 | 86,62 |
| A. Equity | -11 198,71 | -29 017,02 | -41 896,16 | -55 820,86 | -72 833,69 |
| B. Liabilities and provisions for liabilities | 14 285,67 | 29 067,28 | 41 930,03 | 55 877,04 | 72 920,31 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | 13 344,00 | 29 067,28 | 41 930,03 | 55 877,04 | 72 920,31 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.